EP0703905A1
(en)
*
|
1993-06-18 |
1996-04-03 |
Merck & Co. Inc. |
Inhibitors of farnesyl-protein transferase
|
US5719148A
(en)
*
|
1993-10-15 |
1998-02-17 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
US5721236A
(en)
*
|
1993-10-15 |
1998-02-24 |
Schering Corporation |
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US6524832B1
(en)
|
1994-02-04 |
2003-02-25 |
Arch Development Corporation |
DNA damaging agents in combination with tyrosine kinase inhibitors
|
US5700806A
(en)
*
|
1995-03-24 |
1997-12-23 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US5856326A
(en)
*
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
IL117798A
(he)
*
|
1995-04-07 |
2001-11-25 |
Schering Plough Corp |
תרכובות טריציקליות השימושיות לעיכוב פונקציה של פרוטאין - g ולטיפול במחלות ממאירות, ותכשירי רוקחות המכילים אותן
|
US5712280A
(en)
*
|
1995-04-07 |
1998-01-27 |
Schering Corporation |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
IL117797A0
(en)
*
|
1995-04-07 |
1996-08-04 |
Pharmacopeia Inc |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US5801175A
(en)
*
|
1995-04-07 |
1998-09-01 |
Schering Corporation |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
WO1997000252A1
(en)
*
|
1995-06-16 |
1997-01-03 |
Warner-Lambert Company |
Tricyclic inhibitors of protein farnesyltransferase
|
CA2226623A1
(en)
*
|
1995-07-13 |
1997-01-30 |
University Of Cincinnati |
Compounds useful in the treatment of neurofibromatosis
|
NZ326035A
(en)
*
|
1995-12-22 |
2000-01-28 |
Schering Corp |
Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases
|
AU769687B2
(en)
*
|
1995-12-22 |
2004-01-29 |
Merck Sharp & Dohme Corp. |
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US5874442A
(en)
*
|
1995-12-22 |
1999-02-23 |
Schering-Plough Corporation |
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
|
EP0880320A4
(en)
*
|
1996-01-30 |
1999-06-16 |
Merck & Co Inc |
INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
|
US6117641A
(en)
|
1996-04-11 |
2000-09-12 |
Mitotix, Inc. |
Assays and reagents for identifying anti-fungal agents and uses related thereto
|
US6727082B1
(en)
|
1996-04-11 |
2004-04-27 |
Gpc Biotech Inc. |
Assays and reagents for identifying anti-fungal agents, and uses related thereto
|
JP2001513622A
(ja)
|
1996-04-11 |
2001-09-04 |
マイトティックス インコーポレーテッド |
抗菌剤の同定のためのアッセイおよび試薬、並びにそれらに関連する利用
|
DE19624659A1
(de)
|
1996-06-20 |
1998-01-08 |
Klinge Co Chem Pharm Fab |
Neue Pyridylalken- und Pyridylalkinsäureamide
|
US6451816B1
(en)
|
1997-06-20 |
2002-09-17 |
Klinge Pharma Gmbh |
Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
|
DE19624704A1
(de)
|
1996-06-20 |
1998-01-08 |
Klinge Co Chem Pharm Fab |
Neue Pyridylalkansäureamide
|
US5925757A
(en)
*
|
1996-07-26 |
1999-07-20 |
Schering Corporation |
Method for preparing carboxamides
|
PE92098A1
(es)
*
|
1996-07-31 |
1998-12-31 |
Schering Corp |
N-cianoiminas triciclicas utiles como inhibidores de transferasa de proteina farnesilo
|
WO1998011106A1
(en)
*
|
1996-09-13 |
1998-03-19 |
Schering Corporation |
Tricyclic compounds useful as fpt inhibitors
|
CA2266015C
(en)
*
|
1996-09-13 |
2003-12-30 |
Schering Corporation |
Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
|
EP0927179B1
(en)
*
|
1996-09-13 |
2003-08-13 |
Schering Corporation |
Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
|
US6030982A
(en)
|
1996-09-13 |
2000-02-29 |
Schering Corporationm |
Compounds useful for inhibition of farnesyl protein transferase
|
US5965570A
(en)
*
|
1996-09-13 |
1999-10-12 |
Schering Corporation |
Tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
|
US5994364A
(en)
*
|
1996-09-13 |
1999-11-30 |
Schering Corporation |
Tricyclic antitumor farnesyl protein transferase inhibitors
|
US5945429A
(en)
*
|
1996-09-13 |
1999-08-31 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
WO1998011097A1
(en)
*
|
1996-09-13 |
1998-03-19 |
Schering Corporation |
Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase
|
US5861395A
(en)
*
|
1996-09-13 |
1999-01-19 |
Schering Corporation |
Compounds useful for inhibition of farnesyl proteins transferase
|
NZ334454A
(en)
*
|
1996-09-13 |
2000-08-25 |
Schering Corp |
substituted benzocycloheptapyridine derivatives and medicaments
|
US6040305A
(en)
*
|
1996-09-13 |
2000-03-21 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
KR20000036120A
(ko)
*
|
1996-09-13 |
2000-06-26 |
둘락 노먼 씨. |
파르네실 단백질 트랜스퍼라제에 대한 트리사이클릭 저해제
|
WO1998011098A1
(en)
*
|
1996-09-13 |
1998-03-19 |
Schering Corporation |
Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
|
CZ84299A3
(cs)
*
|
1996-09-13 |
1999-09-15 |
Schering Corporation |
Sloučeniny vhodné pro inhibici farnesylproteintransferasy
|
US6071907A
(en)
*
|
1996-09-13 |
2000-06-06 |
Schering Corporation |
Tricyclic compounds useful as FPT inhibitors
|
SK33599A3
(en)
*
|
1996-09-13 |
2000-03-13 |
Schering Corp |
Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
|
US5958890A
(en)
*
|
1996-09-13 |
1999-09-28 |
Schering Corporation |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
KR20000036059A
(ko)
*
|
1996-09-13 |
2000-06-26 |
둘락 노먼 씨. |
G-단백질 기능의 억제 및 증식성 질환의 치료에 유용한트리사이클릭 화합물
|
US5985879A
(en)
*
|
1996-09-13 |
1999-11-16 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6130229A
(en)
*
|
1996-10-09 |
2000-10-10 |
Schering Corporation |
Tricyclic compounds having activity as RAS-FPT inhibitors
|
US5972966A
(en)
*
|
1996-12-05 |
1999-10-26 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5898810A
(en)
*
|
1997-04-04 |
1999-04-27 |
Minnesota Mining And Manufacturing Company |
Illumination waveguide and method for producing same
|
US5760232A
(en)
*
|
1997-06-16 |
1998-06-02 |
Schering Corporation |
Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds
|
US6689789B2
(en)
|
1997-06-17 |
2004-02-10 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
WO1998057965A1
(en)
*
|
1997-06-17 |
1998-12-23 |
Schering Corporation |
Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase
|
US5945430A
(en)
*
|
1997-06-17 |
1999-08-31 |
Schering Corporation |
Aminooxyamide tricyclic inhibitors of farnesyl-protein transferase
|
AU8253798A
(en)
*
|
1997-06-17 |
1999-01-04 |
Schering Corporation |
Novel phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
|
CA2293433C
(en)
*
|
1997-06-17 |
2009-09-29 |
Schering Corporation |
Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors
|
US6576639B1
(en)
|
1997-06-17 |
2003-06-10 |
Schering Corporation |
Compounds for the inhibition of farnesyl protein transferase
|
US6239140B1
(en)
|
1997-06-17 |
2001-05-29 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6225322B1
(en)
|
1997-06-17 |
2001-05-01 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6228865B1
(en)
|
1997-06-17 |
2001-05-08 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
EP0993460B1
(en)
*
|
1997-06-17 |
2004-09-15 |
Schering Corporation |
Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
|
HUP0004274A3
(en)
*
|
1997-06-17 |
2002-03-28 |
Schering Corp |
Bispyrido-cycloheptane compounds and pharmaceutical compositions thereof
|
US5852034A
(en)
*
|
1997-06-17 |
1998-12-22 |
Schering Corporation |
Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
|
AU8253498A
(en)
*
|
1997-06-17 |
1999-01-04 |
Schering Corporation |
Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
CN1266433A
(zh)
*
|
1997-06-17 |
2000-09-13 |
先灵公司 |
用于抑制法呢基蛋白转移酶的苯并吡啶并环庚烷化合物
|
IL133447A0
(en)
*
|
1997-06-17 |
2001-04-30 |
Schering Corp |
Compounds useful for inhibition of farnesyl protein transferase
|
US6211193B1
(en)
|
1997-06-17 |
2001-04-03 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6218401B1
(en)
|
1997-06-17 |
2001-04-17 |
Schering Corporation |
Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
|
US6358968B1
(en)
|
1997-06-17 |
2002-03-19 |
Schering Corporation |
N-substituted urea inhibitors of farnesyl-protein transferase
|
US6159984A
(en)
*
|
1997-06-17 |
2000-12-12 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
WO1998057968A1
(en)
*
|
1997-06-17 |
1998-12-23 |
Schering Corporation |
Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase
|
US5939416A
(en)
*
|
1997-06-17 |
1999-08-17 |
Schering Corporation |
Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors
|
US5925639A
(en)
*
|
1997-06-17 |
1999-07-20 |
Schering Corporation |
Keto amide derivatives useful as farnesyl protein transferase inhibitors
|
ZA985205B
(en)
*
|
1997-06-17 |
1998-12-15 |
Schering Corp |
Novel n-substituted urea inhibitors of arnesyl-protein transferase
|
US5877177A
(en)
*
|
1997-06-17 |
1999-03-02 |
Schering Corporation |
Carboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
BR9811470A
(pt)
*
|
1997-06-17 |
2000-09-19 |
Schering Corp |
Derivados de benzo (5,6) ciclohepta (1,2-b) piridina para a inibição da transferase da proteìna farnesil.
|
US6051582A
(en)
*
|
1997-06-17 |
2000-04-18 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6037166A
(en)
*
|
1997-06-17 |
2000-03-14 |
Schering Corporation |
Enzymatic kinetic resolution of an intermediate useful for preparing substituted tricyclics
|
US5925648A
(en)
*
|
1997-07-29 |
1999-07-20 |
Schering Corporation |
Tricyclic N-cyanoimines useful as inhibitors of a farnesyl-protein transferase
|
US5958940A
(en)
*
|
1997-09-11 |
1999-09-28 |
Schering Corporation |
Tricyclic compounds useful as inhibitors of farnesyl-protein transferase
|
DE19756212A1
(de)
*
|
1997-12-17 |
1999-07-01 |
Klinge Co Chem Pharm Fab |
Neue, mit einem cyclischen Imid substituierte Pyridylalkan-, alken- und -alkincarbonsäureamide
|
DE19756235A1
(de)
|
1997-12-17 |
1999-07-01 |
Klinge Co Chem Pharm Fab |
Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide
|
US6903118B1
(en)
|
1997-12-17 |
2005-06-07 |
Klinge Pharma Gmbh |
Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
|
US6096757A
(en)
|
1998-12-21 |
2000-08-01 |
Schering Corporation |
Method for treating proliferative diseases
|
US6632455B2
(en)
|
1997-12-22 |
2003-10-14 |
Schering Corporation |
Molecular dispersion composition with enhanced bioavailability
|
US6307048B1
(en)
|
1998-11-20 |
2001-10-23 |
Schering Corporation |
Enantioselective alkylation of tricyclic compounds
|
US6362188B1
(en)
|
1998-12-18 |
2002-03-26 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
US6372747B1
(en)
|
1998-12-18 |
2002-04-16 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
JP2002533336A
(ja)
|
1998-12-18 |
2002-10-08 |
シェーリング コーポレイション |
三環式ファルネシルタンパク質トランスフェラーゼインヒビター
|
US6800636B2
(en)
|
1998-12-18 |
2004-10-05 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
ID29065A
(id)
*
|
1998-12-18 |
2001-07-26 |
Schering Corp |
Penghambat-penghambat farnesil protein transferase
|
EP1031564A1
(en)
|
1999-02-26 |
2000-08-30 |
Klinge Pharma GmbH |
Inhibitors of cellular nicotinamide mononucleotide formation and their use in cancer therapy
|
US6316462B1
(en)
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
US7342016B2
(en)
*
|
2000-08-30 |
2008-03-11 |
Schering Corporation |
Farnesyl protein transferase inhibitors as antitumor agents
|
US6881841B2
(en)
|
2000-11-22 |
2005-04-19 |
Tsutomu Takeuchi |
Dibenzosuberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives
|
WO2002044164A1
(en)
*
|
2000-11-29 |
2002-06-06 |
Schering Corporation |
0ovel farnesyl protein transferase inhibitors
|
AU2002236813A1
(en)
*
|
2001-01-22 |
2002-07-30 |
Schering Corporation |
Treatment of malaria with farnesyl protein transferase inhibitors
|
US6703400B2
(en)
|
2001-02-23 |
2004-03-09 |
Schering Corporation |
Methods for treating multidrug resistance
|
AU2002359412A1
(en)
|
2001-11-13 |
2003-05-26 |
Bristol-Myers Squibb Company |
Process for the preparation of 3,7-disubstituted-2,3,4,5- tetrahydro-1h-1,4-benzodiazepine compounds
|
CA2525968A1
(en)
|
2003-06-25 |
2005-01-13 |
Schering Corporation |
Metabolites of tricyclic amides useful for inhibition of g-protein function and methods of treatment of proliferative diseases
|
RU2006106768A
(ru)
*
|
2003-08-07 |
2007-09-20 |
Шеринг Корпорейшн (US) |
Новые ингибиторы фарнезилпротеинтрансферазы как противоопухолевые агенты
|
EP1656156A2
(en)
|
2003-08-13 |
2006-05-17 |
Children's Hospital Medical Center |
Mobilization of hematopoietic cells
|
US7585864B2
(en)
|
2004-12-13 |
2009-09-08 |
Schering Corporation |
Farnesyl protein transferase inhibitors and their use to treat cancer
|
US20060205755A1
(en)
*
|
2004-12-21 |
2006-09-14 |
Schering Corporation |
Novel farnesyl protein transferase inhibitors as antitumor agents
|
US8362075B2
(en)
|
2005-05-17 |
2013-01-29 |
Merck Sharp & Dohme Corp. |
Cyclohexyl sulphones for treatment of cancer
|
GB0603041D0
(en)
|
2006-02-15 |
2006-03-29 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
SI2010528T1
(en)
|
2006-04-19 |
2018-02-28 |
Novartis Ag |
6-O-substituted benzoxazole and benzothiazole compounds and procedures for inhibiting CSF-1R signaling
|
WO2008039327A2
(en)
|
2006-09-22 |
2008-04-03 |
Merck & Co., Inc. |
Method of treatment using fatty acid synthesis inhibitors
|
US20110218176A1
(en)
|
2006-11-01 |
2011-09-08 |
Barbara Brooke Jennings-Spring |
Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
|
PL2336120T3
(pl)
|
2007-01-10 |
2014-12-31 |
Msd Italia Srl |
Kombinacje zawierające indazole podstawione grupą amidową jako inhibitory polimerazy poli(ADP-rybozy) (PARP)
|
MX2009009304A
(es)
|
2007-03-01 |
2009-11-18 |
Novartis Ag |
Inhibidores de cinasa pim y metodos para su uso.
|
CA2685967A1
(en)
|
2007-05-21 |
2008-11-21 |
Novartis Ag |
Csf-1r inhibitors, compositions, and methods of use
|
CA2690191C
(en)
|
2007-06-27 |
2015-07-28 |
Merck Sharp & Dohme Corp. |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
WO2010114780A1
(en)
|
2009-04-01 |
2010-10-07 |
Merck Sharp & Dohme Corp. |
Inhibitors of akt activity
|
US8765747B2
(en)
|
2009-06-12 |
2014-07-01 |
Dana-Farber Cancer Institute, Inc. |
Fused 2-aminothiazole compounds
|
PE20121172A1
(es)
|
2009-10-14 |
2012-09-05 |
Merck Sharp & Dohme |
Piperidinas sustituidas con actividad en la hdm2
|
US9180127B2
(en)
|
2009-12-29 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
BR112012023021A2
(pt)
|
2010-03-16 |
2016-05-31 |
Dana Farber Cancer Inst Inc |
compostos de indazol e seus usos
|
US8999957B2
(en)
|
2010-06-24 |
2015-04-07 |
Merck Sharp & Dohme Corp. |
Heterocyclic compounds as ERK inhibitors
|
CA2805265A1
(en)
|
2010-08-02 |
2012-02-09 |
Merck Sharp & Dohme Corp. |
Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)
|
CA2807307C
(en)
|
2010-08-17 |
2021-02-09 |
Merck Sharp & Dohme Corp. |
Rna interference mediated inhibition of hepatitis b virus (hbv) gene expression using short interfering nucleic acid (sina)
|
EP2608669B1
(en)
|
2010-08-23 |
2016-06-22 |
Merck Sharp & Dohme Corp. |
NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
|
US8946216B2
(en)
|
2010-09-01 |
2015-02-03 |
Merck Sharp & Dohme Corp. |
Indazole derivatives useful as ERK inhibitors
|
US9242981B2
(en)
|
2010-09-16 |
2016-01-26 |
Merck Sharp & Dohme Corp. |
Fused pyrazole derivatives as novel ERK inhibitors
|
EP2632472B1
(en)
|
2010-10-29 |
2017-12-13 |
Sirna Therapeutics, Inc. |
Rna interference mediated inhibition of gene expression using short interfering nucleic acids (sina)
|
US9351965B2
(en)
|
2010-12-21 |
2016-05-31 |
Merck Sharp & Dohme Corp. |
Indazole derivatives useful as ERK inhibitors
|
IN2013MN02170A
(he)
|
2011-04-21 |
2015-06-12 |
Piramal Entpr Ltd |
|
WO2013063214A1
(en)
|
2011-10-27 |
2013-05-02 |
Merck Sharp & Dohme Corp. |
Novel compounds that are erk inhibitors
|
EP3569598A1
(en)
|
2011-11-17 |
2019-11-20 |
Dana Farber Cancer Institute, Inc. |
Inhibitors of c-jun-n-terminal kinase (jnk)
|
EP2844261B1
(en)
|
2012-05-02 |
2018-10-17 |
Sirna Therapeutics, Inc. |
SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
|
EP2895472B1
(en)
*
|
2012-08-09 |
2016-11-23 |
VIIV Healthcare UK (No.5) Limited |
Tricyclic alkene derivatives as HIV attachment inhibitors
|
WO2014052563A2
(en)
|
2012-09-28 |
2014-04-03 |
Merck Sharp & Dohme Corp. |
Novel compounds that are erk inhibitors
|
EP2909194A1
(en)
|
2012-10-18 |
2015-08-26 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
WO2014063061A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
WO2014063054A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
|
MX363243B
(es)
|
2012-11-28 |
2019-03-14 |
Merck Sharp & Dohme |
Composiciones para tratar cáncer y usos de dichas composiciones.
|
BR112015013611A2
(pt)
|
2012-12-20 |
2017-11-14 |
Merck Sharp & Dohme |
composto, e, composição farmacêutica
|
EP2951180B1
(en)
|
2013-01-30 |
2018-05-02 |
Merck Sharp & Dohme Corp. |
2,6,7,8 substituted purines as hdm2 inhibitors
|
EP3041938A1
(en)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
CN104418836A
(zh)
*
|
2013-09-09 |
2015-03-18 |
天津药物研究院 |
双酰胺类化合物及其制备方法和用途
|
AU2014337044A1
(en)
|
2013-10-18 |
2016-05-05 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
|
ES2676734T3
(es)
|
2013-10-18 |
2018-07-24 |
Syros Pharmaceuticals, Inc. |
Compuestos heteroatómicos útiles para el tratamiento de enfermedades proliferativas
|
US10017477B2
(en)
|
2014-04-23 |
2018-07-10 |
Dana-Farber Cancer Institute, Inc. |
Janus kinase inhibitors and uses thereof
|
WO2015164604A1
(en)
|
2014-04-23 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged janus kinase inhibitors and uses thereof
|
JO3589B1
(ar)
|
2014-08-06 |
2020-07-05 |
Novartis Ag |
مثبطات كيناز البروتين c وطرق استخداماتها
|
JP6854762B2
(ja)
|
2014-12-23 |
2021-04-07 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
サイクリン依存性キナーゼ7(cdk7)の阻害剤
|
JP6861166B2
(ja)
|
2015-03-27 |
2021-04-21 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
サイクリン依存性キナーゼの阻害剤
|
AU2016276963C1
(en)
|
2015-06-12 |
2021-08-05 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
CA2996978A1
(en)
|
2015-09-09 |
2017-03-16 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
JOP20190055A1
(ar)
|
2016-09-26 |
2019-03-24 |
Merck Sharp & Dohme |
أجسام مضادة ضد cd27
|
MX2019012233A
(es)
|
2017-04-13 |
2020-01-14 |
Aduro Biotech Holdings Europe Bv |
Anticuerpos anti-sirpa.
|
WO2019094311A1
(en)
|
2017-11-08 |
2019-05-16 |
Merck Sharp & Dohme Corp. |
Prmt5 inhibitors
|
WO2019148412A1
(en)
|
2018-02-01 |
2019-08-08 |
Merck Sharp & Dohme Corp. |
Anti-pd-1/lag3 bispecific antibodies
|
WO2020033284A1
(en)
|
2018-08-07 |
2020-02-13 |
Merck Sharp & Dohme Corp. |
Prmt5 inhibitors
|
US20210277009A1
(en)
|
2018-08-07 |
2021-09-09 |
Merck Sharp & Dohme Corp. |
Prmt5 inhibitors
|
WO2021086133A1
(ko)
*
|
2019-10-31 |
2021-05-06 |
(주)제이디바이오사이언스 |
삼환식 화합물 및 이의 약학적 용도
|